DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation | Patent Number 10022379

US 10022379 B2
Application Number15403705
Publication NumberUS 20170119773 A1
Pendency1 year, 6 months, 7 days
Filled DateJan 11, 2017
Priority DateAug 8, 2008
Publication DateMay 4, 2017
Expiration DateAug 7, 2028
Inventor/ApplicantsTakaaki Nishioka
Megumi Maruyama
Hikaru Fujita
Thomas Friedl
Michael Braun
Takaaki NISHIOKA
Michael BRAUN
Kenji EGUSA
Hikaru FUJITA
Kenji Egusa
Thomas FRIEDL
Megumi MARUYAMA
ExaminesCHANG, KYUNG SOOK
Art Unit1613
Technology Center1600
Assignments
Boehringer Ingelheim International Gmbh
Current
Boehringer Ingelheim International Gmbh
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.